Nipah Vaccine :: Human Trials Of ‘Nipah’ Vaccine From April... Japanese Researchers Prepare...

Visakhapatnam, February 8, AIMA Media News: A crucial step is about to be taken in the medical field to control the deadly ‘Nipah’ virus. A vaccine developed by Japanese researchers as an antidote to this virus, which spreads through the air and contaminated food and severely affects the brain, is ready for human trials from April. Scientists from the Institute of Medical Science at the University of Tokyo have achieved this feat.

Nipah Vaccine Clinical Trials:

As part of the research, the vaccine will be tested on approximately 40 healthy volunteers in the first phase. The primary focus will be on determining how safe the vaccine is for humans and whether it causes any side effects. Scientists will also monitor how it stimulates the immune system to fight the Nipah virus in the body.

About the Nipah Virus:

Nipah is a virus that spreads from animals, especially bats, to humans. It has a very high fatality rate. The World Health Organization (WHO) has already warned that there is a possibility of death in about 40% to 75% of cases. It starts with severe fever, headache, and respiratory problems, and can lead to serious complications such as encephalitis (brain inflammation).

Importance:

Currently, there are no specific medicines or vaccines available for the Nipah virus. Treatment is currently being provided based solely on the symptoms. If the experiments by Japanese scientists are successful, it will be a milestone in preventing the spread of this pandemic in the future.

---- M Venkata T Reddy, News Editor And Investigative Journalist.